From: Neuropsychiatric lupus erythematosus in a cohort of Egyptian patients
Drugs | Group I (n = 68) | Group II (n = 66) | p |
---|---|---|---|
Steroids (mg/day) | |||
 < 20 | 23 (33.8%) | 18 (27.3%) |  |
 20–40 | 38 (55.9%) | 40 (60.6%) | 0.705 |
 > 40 | 7 (10.3%) | 8 (12.1%) |  |
Pulse steroid | 35 (51.5%) | 30 (45.5%) | 0.486 |
Anti-malarials | 59 (86.8%) | 54 (81.8%) | 0.431 |
Azathioprine | 50 (73.5%) | 49 (74.2%) | 0.925 |
Mycophenolate mofetil | 8 (11.8%) | 6 (9.1%) | 0.613 |
Cyclophosphamide | 21 (30.9%) | 20 (30.3%) | 0.942 |